These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16995977)

  • 1. [An analysis of the relationship between HBV DNA and HBeAg expression and mortality in 799 severe hepatitis patients].
    Wang RB; Zhou GQ; Jiang YY; Sun FX; Wu YZ; Sun JY; Meng PP; Niu SM
    Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):655-7. PubMed ID: 16995977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of HBeAg positivity/negativity and HBV DNA loads on the prognosis of chronic severe hepatitis B].
    Sun QF; Lü Y; Xu DZ; Lan XY; Liu JY; Sun XJ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):410-3. PubMed ID: 16792862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors related to the outcome of patients with chronic severe hepatitis B and effectiveness of antivirus therapy].
    Wu YZ; Zhao FL; Zhang CZ; Li MH; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):120-2. PubMed ID: 17653310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prospective study of the clinical features and outcome of HBeAg-negative and HBeAg-positive cirrhosis in patients with chronic type B hepatitis].
    Ma H; Guo F; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1832-5. PubMed ID: 17922993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlations between preS1-antigen, HBV-DNA and HBV serum markers in patients with chronic hepatitis B].
    Zhou H; Jiang CW; Qian JL; Li SJ; Liang JL; Chen XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1184-6. PubMed ID: 18676258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment].
    Xu JH; Yu YY; Si CW; Chen XY; Han ZH; Chen Y; Li XY
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(41):2902-5. PubMed ID: 20137646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
    Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum chemokine RANTES level with serum biochemical indices, HBeAg and HBV DNA load in patients with chronic hepatitis B].
    Zhang K; Xu QH; Chen LB; Shu X; Chen N; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):188-90. PubMed ID: 20104774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK; Papatheodoridis GV; Sevastianos V; Cholongitas E; Papaioannou C; Hadziyannis SJ
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The contrast study of Pre-S1 protein, HBV-DNA and HBeAg in diagnosing viral replication in patients with chronic hepatitis B].
    Li Q; Sun GZ; Wei YX; Min YY; Cong YL; Ou XJ; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):134-6. PubMed ID: 15059293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
    Gish RG; Chang TT; Lai CL; de Man R; Gadano A; Poordad F; Yang J; Brett-Smith H; Tamez R
    J Viral Hepat; 2010 Jan; 17(1):16-22. PubMed ID: 19622117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
    Xie Y; Zhao H; Dai WS; Xu DZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBV markers in severe hepatitis B].
    Fan X; Ren P; Weng S; Hu G
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(4):391-2. PubMed ID: 11189403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy.
    Shin JW; Chung YH; Choi MH; Kim JA; Ryu SH; Jang MK; Kim IS; Park NH; Lee HC; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):844-9. PubMed ID: 15946130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.